Eden Research plc (LON:EDEN – Get Free Report) traded up 2.8% on Tuesday following insider buying activity. The stock traded as high as GBX 4.18 ($0.05) and last traded at GBX 3.70 ($0.05). 12,234,783 shares changed hands during trading, an increase of 664% from the average session volume of 1,602,016 shares. The stock had previously closed at GBX 3.60 ($0.04).
Specifically, insider Alexander John Abrey bought 540,540 shares of the stock in a transaction dated Tuesday, January 28th. The shares were acquired at an average cost of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($26,902.58).
Eden Research Stock Performance
The company has a quick ratio of 2.42, a current ratio of 3.80 and a debt-to-equity ratio of 1.25. The stock has a 50-day moving average of GBX 3.88 and a 200 day moving average of GBX 4.02. The stock has a market cap of £19.73 million, a PE ratio of -200.00 and a beta of 0.92.
About Eden Research
Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.
Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.
Recommended Stories
- Five stocks we like better than Eden Research
- What Are the U.K. Market Holidays? How to Invest and Trade
- What Does the Future Hold for Eli Lilly?
- How to Short a Stock in 5 Easy Steps
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- 3 Consumer Stocks Call Option Traders Are Betting Big On
Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.
